Key Insights

Highlights

Treatment Research

2 treatments under study, led by Azithromycin 15 Loteprednol 05 Separately

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01721694Phase 3Withdrawn

Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection

Showing all 1 trials

Research Network

Common Treatments

  • Azithromycin 15 Loteprednol 05 Separately1
  • Azithromycin 15loteprednol 05 Placebo1

Active Sponsors

  • Adapt Produtos Oftalmológicos Ltda.1

Top Investigators

Related Conditions

  • Keratitis1
  • Ocular Inflammation1
  • Conjunctivitis Bacterial1

Activity Timeline